VIC Tech is a life science venture studio that builds companies around high-impact life science innovations sourced from leading research institutions worldwide. Our process begins with in-depth analysis of life science sub-sectors to uncover white-space opportunities ripe for disruption. We then identify, vet, and license the most promising technologies for commercialization.
Once a company is formed, VIC provides hands-on support across executive leadership, scientific and engineering development, accounting, marketing, and more. We guide portfolio companies through key milestones and fundraising efforts, with a typical path to exit via acquisition.
VIC operates nationally, with specialized offices focusing on medical devices, diagnostics, and therapeutics. Our portfolio companies are built around technologies exclusively licensed from top global institutions—ranging from breakthrough medical devices to transformative therapeutics addressing critical unmet needs.
VIC also manages the VIC Investor Network (VIN), giving members access to thoroughly vetted investment opportunities within our cost-efficient, risk-mitigating ecosystem. Our companies have a strong track record of rapid value creation. Experienced investors benefit from attractive early-stage valuations and high return potential, while new investors can participate with low minimums, gaining exposure to multiple ventures as they build confidence.
